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Abstract 
Neural stem cells (NSCs) are multipotent self-renewing cells that could be used in cellular-based 
therapy for a wide variety of neurodegenerative diseases including Alzheimer’s diseases (AD), 
Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). Being 
multipotent in nature, they are practically capable of giving rise to major cell types of the nervous 
tissue including  neurons, astrocytes and oligodendrocytes. This is in marked contrast to neural 
progenitor cells which are committed to a specific lineage fate. In previous studies, we have 
demonstrated the ability of NSCs isolated from human olfactory bulb (OB) to survive, proliferate, 
differentiate, and restore cognitive and motor deficits associated with AD, and PD rat models, 
respectively. The use of carbon nanotubes (CNTs) to enhance the survivability and differentiation 
potential of NSCs following their in vivo engraftment have been recently suggested. Here, in order 
to assess the ability of CNTs to enhance the therapeutic potential of human OBNSCs for restoring 
cognitive deficits and neurodegenerative lesions, we co-engrafted CNTs and human OBNSCs in 
TMT-neurodegeneration rat model.  The present study revealed that engrafted human OBNSCS-
CNTs restored cognitive deficits, and neurodegenerative changes associated with TMT-induced rat 
neurodegeneration model. Moreover, the CNTs seemed to provide a support for engrafted 
OBNSCs, with increasing their tendency to differentiate into neurons rather than into glia cells. The  
present study indicate the marked ability of CNTs to enhance the therapeutic potential of human 
OBNSCs which qualify this  novel therapeutic paradigm as a promising candidate for cell-based 
therapy of different neurodegenerative diseases. This article is protected by copyright. All rights 
reserved 
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Introduction 
Alzheimer’s diseases (AD) is a devastating neurodegenerative diseases with no effective cure till now. 
AD is characterized by cognitive and memory impairments mainly due to loss of cholinergic neurons in 
the hippocampus, and brain cortex (1). The AD pathology involves the basal forebrain cholinergic 
system, which provide cholinergic input to the neocortex, the hippocampus (2) and the cholinergic 
neurons of the nucleus basalis of Magnocellurais (NBM) in rodent and nonhuman primates which is the 
analogous to nucleus basalis of Mynert (NBM) in human (3). The loss of neurons and astrocytic gliosis 
that had been encountered in the aforementioned areas, are the main reasons that induce aggressive loss 
of memory function (4). 
Neural stem cells (NSCs) are multipotent cells resides in different brain regions such as sub ventricular, 
and  sub granular zone of hippocampus (5), and they hold a great opportunity for the future of 
treatments of neurodegenerative diseases such as AD, PD, ALS, and MS (6).  
Obtaining NSCs from adult human olfactory bulb (OB) would allow auto transplantation for traumatic 
and neurodegenerative diseases, and thus provide biosafety, histocompatibility, and does not raise the 
ethical issues due to the use of embryonic material (7).  
       In previous studies, we have isolated NSCs from the human OB. These OBNSCs we proliferated in 
culture, and then engrafted in three rat models for AD, PD, and spinal cord injury (SCI). These studies 
demonstrated the ability of engrafted human OBNSCs to proliferate, differentiated into different 
neuronal and glial elements, and to restore cognitive and motor deficits associated with AD (8), and PD 
(9). In our SCI study, despite the marker ability of the engrafted human OBNSCs to proliferate and 
differentiate following transplantation, no significant improvement was recorded in motor function  
(10). An important feature for the engrafted human OBNSCs in the aforementioned three independent 
studies was the absence of any tumor formation, a crucial finding that might qualify OBNSC for safe 
application at the clinical level (8-10). Engrafted NSCs in different neurodegenerative insults 
proliferated, migrated and differentiated into different neuronal subtypes including cholinergic neurons 
(10). Other positive influences induced by NSCs transplantation included their ability to enhance the 
survival of existing neuronal circuitry through immune modulation, neurotrophic influence (11, 12) and 
enzyme replacement, and migration (11-17). 
 
      Recently, the use of nanomaterials such as single carbone nanotubes (CNTs) have been suggested as 
effective substrate for different cellular sources. Such CNTs have been reported to provide a scaffolds to 
control the proliferation and differentiation potential of loaded cells. Moreover, such biological scaffolds 
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could also be loaded with different effective molecules such as growth factors and cytokines (18). 
Specific to the central nervous system architecture and molecular uniqueness, neural cells adhere to 
specific extracellular matrix (ECM) formed of fibrillary proteins. This dynamic ECM interacts with 
different neuronal and glial elements to modulate cell growth, survival, and differentiation potential. 
Moreover, a loss of contact between the ECM and neuronal cellular elements may induce cell apoptosis 
(19). It is for this reason that attention has recently been given to different nanostructured biomaterials 
that mimic the unique histo-architecture of CNS tissue. 
 
The unique properties of CNTs which are formed of single or multiple sheets of graphene, their 
mechanical strength, stability, light weight, and rich electronic criteria (20) have attracted the attention 
of several neuroscientists to use CNT as scaffolds for  neural cell growth. CNTs could be either used 
alone or after addition of various chemical groups, and in both cases they are biocompatible with 
neuronal cell proliferation, growth and adhesion.  
 
Besides neural cells, other cell types such as stem cells and glia cells can successfully grow on CNT 
scaffolds. A marked modulation in neuronal growth has been demonstrated by different types of 
functionalized CNTs. The neurite growth of hippocampal neurons was enhanced by growing on 
positively charged CNTs, and the mechanical properties and  conductivity of CNTs have been shown to 
modulate neuronal morphology. Provision of CTNs to the sites of CNS injuries enhances the 
regeneration of lost synaptic connections, induce neurite outgrowth which might aid in the regeneration 
process (21). Despite promising outlook for such novel biological scaffolds as promising direction for 
enhancing cellular based therapy, assessment of such direction of therapeutic intervention for 
mammalian neurodegenerative changes is still far from complete (22). 
           Intraperitoneal injection of TMT selectively induces neuro-inflammations, neuronal 
death which is reflected clinically as cognitive impairment and seizures (23, 24). In particular, 
TMT-induced neurodegeneration has been found useful in the study of AD (25). In the 
present study, our previous findings regarding the marked ability of human OBNSCs to 
proliferate, differentiate, and restore lost neural functions in in vivo rat model of AD, and PD, 
and the ability of CNT to enhance neurite outgrowth have prompted us to investigate the 
therapeutic potential of nanotubes impregnated OBNSC and their ability to restore behavioral 
and cognitive deficit in a TMT-induced rat model of neurodegeneration.  
Materials and Methods 
Male Wister albino rats weighing 220 ± 25 g were used for the experiments. Animals were 
acclimatized to the animal house conditions (12:12 hr. light/dark cycle and under a temperature-
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controlled environment of 24 ± 1 ° C) for a week. Standard pelleted feed and water were provided 
ad libitum. All experimental procedures were conducted according to the Institutional Animal Care 
and Use Committee guidelines at the University of Mansoura, Egypt. The animals were divided into 
three groups.  
Animals Experimental protocol Groups 
10 Control Group-I 
16 Lesioned in which 6mg/kg body wt. of Trimethyltin (TMT) 
was injected intraperitoneally 
Group-II 
20 Lesioned with Nanotubes impregnated adult human olfactory 
bulb neural stem cells (CNT/OBNSCs) transplantation  
Group-III 
Experimental induction of trimethyltin chloride (TMT)  cognitive dysfunction model 
Trimethyltin chloride (TMT) (Sigma, Germany) was dissolved in 0.9% saline and intraperitoneal 
(ip) injected  at a dose of 6mg/kg body weight according to previously reported method (26). The 
rat returned to its cage and allowed to rest at 12:12 hr. light/dark cycle and under a temperature-
controlled environment of 24 ± 1 ° C for 4 weeks. Standard pelleted feed and water were provided 
ad libitum. The testing of different variants such as memory and exploratory task were conducted at 
the end of the 4 weeks. 
Behavioural Assessment (Morris Water Maze Test)  
The learning and memory functions of TMT-treated and CNTs/OBNSCs engrafted rats were 
assessed using Morris water maze (MWM) test (27). To exclude any effects of TMT on the visual 
acuity of rats, we used a visible platform that was extended 1 cm above the water level of MWM. 
Rats were habituated to the MWM swimming pool by allowing them to swim freely (four trials 
from different directions North, West, East and South) for 60 seconds to reach and climp the visible 
platform.  
Next, three blocks of five trials (a total of 15 trials) for cue training were conducted during which 
no cues were provided for the rats except a guide for the platform. Two scores were recorded for 
each trial: a. Escape latency (time needed to reach submerged platform), and b. Quadrant time (time 
spent in the platform’s quadrant after removal of the platform). The time window used for recording 
these scores were 7th day post-training, four and twelve weeks after induction of cognitive 
dysfunction by TMT, and after CNT/OBNSCs engraftment. 
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Culturing of Human Olfactory Bulb NSCs 
Frozen vials of human OBNSCS were obtained as gift from Institute of Neurosurgery, Catholic 
University, Rome, Italy. Informed consent was obtained according to protocols approved by the 
Ethical Committee of the Catholic University. After thawing, the cells were dissociated using 1% 
Accutase (Invitrogen), and were cultures in DMEM/F12 (1:1) serum-free medium (Invitrogen, 
Carlsband, CA) containing L glutamine 2 mM, glucose 0.6%, putrescine 9.6 ug/ml, progesterone 
0.025 mg/ml, sodium selenite 5.2 ng/ml, insulin 0.025 mg/ ml, apo-transferrin sodium salt 0.1 
mg/ml, sodium bicarbonate 3 mM, Hepes 5 mM, BSA 4 mg/ml, heparin 4 ug/ml, human 
recombinant EGF (20 ng/ml; PeproTech, Rocky Hill, NJ), human recombinant bFGF (10 ng/ml; 
PeproTech), and LIF (20 ng/ml; Immunological Sciences, Rome, Italy) (28).  
Transfection and infection 
 
Lipofectamine reagent (Invitrogen) were used to transiently transfect human embryonic kidney 
(HEK)-293T cells in log-phase growth with LV-GFP plus helper plasmids to produce virions (29). 
Two days after transfection, media containing virions was collected and transferred directly onto 
OBNSCs. Lentiviral infection was performed in the presence of polybrene solution at 8 mg/ml 
(Sigma–Aldrich). Antibiotic G418 (Euroclone) was added to the cells at 400 mg/ml over time for 
OBNS/PC selection and maintenance. 
CNT/OBNSCs preparation 
After reaching 80% confluence, the formed OBNSCs neurospheres were collected, and 
dissociated into single cells by accutase treatment. They were then suspended in artificial CSF 
(Sigma-Aldrich) at 50,000 cells/µL, and were kept on ice until transplantation.  Cell viability was 
checked by trypan blue exclusion test, and the total number of cells was determined using a 
hemocytometer. 
Multiwalled Carbon Nanotubes "MWCNT" (Chengdu Organic Chemicals Co., Ltd, Chinese 
Academy of Sciences) with outer diameter "OD"~50-60 nm and length ~10-20 µm, dissolved in 
Phosphate buffer saline (PBS) at concentration up to 100µg/ml. (As MWCNTs are hydrophobic so, 
we need to make a homogenous suspension of them using mechanical way “magnetic stirrer” to be 
equally distributed in the solution without using any chemical chargeable solvent for dispersion the 
MWCNT which may affect the cellular viability) 
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Four weeks following TMT administration, the lesioned rats were anesthetized and stereotaxically 
injected at CA1region with 4µL of  CNT/OBNSCs mixture(1µl MWCNT+3µl 
OBNSCs"150,000cells" at the following coordinates: (±2.5mm (ML), -3.5mm (AP), 2.5 mm (VD)).  
Animals and surgery for CNT/OBNSCs transplantation  
Atropine sulfate was given as pre-anesthetic medication, and the rats were anaesthetized by i.p. 
injection of Ketamine (60 mg/kg body weight) and Xylazine (20 mg/kg body weight). The animals 
were fixed into a stereotaxic frame, and an incision was made to expose the skull. A bilateral 
infusion of CNT/OBNSCs (4μl) were injected into the CA1 region using 10-μl Hamilton syringe at 
the following coordinate from bregma:  ± 2.5mm medio-lateral  (ML), -3.5 mm  anterio-posterior ( 
AP),  2.7 mm ventro-dorsal  (VD) according to the brain atlas of  (30). The injection was given over 
a 5 minutes timeframe, and needle was left in the injection site for 2 minutes to avoid oozing of 
injected cells. Rats we subjected to a post-operative care regime that included I.M. injection of 
antibiotics (penicillin (20,000 U), analgesic (nalorphine), I.P. injection of glucose for 3 days. The 
rat returned to its cage and allowed to rest with special post-operative care and fully controlled 
temperature and adjusted light /dark cycle with fine and easily digestible food and dry, clean and 
soft litter. Clean drinking water ad lipitum. 
 Animals receiving grafts were immunosuppressed via daily subcutaneous injections of 
cyclosporine (10 mg/kg bw; Biomol), started one day before grafting and finished on the day of 
sacrifice.  
Samples collection 
The lesioned group samples were collected ; three rats were euthanized after 2, 4, 8 and 16 weeks 
post TMT administration   
The CNT/OBNSCs engrafted group samples were collected; four rats were euthanized after1, 2, 4, 
6 and 8 weeks following CNT/OBNSCs transplantation. The brain was dissected, and the 
hippocampi were collected and fixed in 4% paraformaldehyde, and were processed for paraffin 
sectioning. 
Histological Analysis  
Tissue fixation and processing for light microscope (LM) 
Collected hippocampi were fixed in 10% neutral buffered formalin, and 4% paraformaldehyde in 
0.1 M phosphate buffer for 24h, dehydrated in ethanol, cleared in xylene and impregnated and 
embedded in paraffin. Five to seven μm section were cut on a rotatory microtome and mounted on 
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glycerol-albumin-coated glass slides. The slides were stained with haematoxylin–eosin (HE) for 
general histological studies, Cresyl Violet stain for Nissl substance (9). 
Enzymatic Immunohistochemical Assessment 
Ten micron (μm) thick serial brain sections were prepared starting from the needle entry site to 1.0 
mm anterior and posterior to injection site. Tracing of GFP-labelled human OBNSCs following 
engraftment was conducted using Anti-GFP (1:2000, rabbit, N-Terminal, Sigma-Aldrich). 
Visualization of the primary antibodies was done using  Biotin-conjugated goat anti rabbit 
secondary antibody labeled with poly-horseradish peroxidase (HRP) conjugate and metal enhanced 
DAB to develop the signal (brown color). 
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Stereological quantification  
 
The stereological quantification was performed according to our previous studies (8). In brief, the 
engrafted GFP-OBNSCs/CNTs were counted using light microscope using enzyme 
immunohistochemistry against GFP. The types of differentiated cells was recognized based on 
nuclear morphology after heamatoxylin nuclear counterstain. The GFP positive cells were counted 
1 mm segments rostral and caudal to the injury site. Cells were counted in four consecutive sections 
using a 40X objective. The number of labeled cells was counted for each type using ImageJ Version 
10.2 software. The numbers of labeled cells was expressed as a percentage of the total number of 
GFP-positive cells counted in each individual type. For each cell analyzed, the values were 
averaged together to get the final percentage.  
 
Statistical analysis 
 
SPSS 16.0 software package was used to process all collected data, and the t test was used for 
comparisons between 2 groups. Multiple group comparisons were achieved by single-effect analysis 
of variance (one-way ANOVA) (Student-Newman-Keuls test). All data are presented as mean ± 
standard deviation (SD). Statistical significance was defined as p<0.05. 
Results 
The TMT  treated animals showed inflammatory changes, death of neurons and glia cells (Fig 1. A, 
B, C). Two weeks post TMT administration, the total number of pyramidal neuron revealed loss of 
cellular architecture (Fig 1. D, E). Some granule cells showing pyknotic nuclei, cell bodies are 
shrunken, most cells showing light and not densely packed nuclei (Fig. 1 F, G). CA3 neurons 
showed vacuolation, and neuronal death with glia cells proliferation (Fig. H). Dissolution of Nissl 
granules was also revealed (Fig. 1 I).  
Behavior results (Morris Water Maze Task) 
The mean latency time in four consecutive days to find and locate the hidden platform in TMT-
Lesioned group was increased significantly (p<0.05) after four weeks. While compared to TMT 
lesioned group after twelve weeks that show significance improvement in memory with decrease 
escape latency. The mean escape latency for non-lesioned rat after training ~3.9 seconds while for 
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TMT lesioned group after four weeks~19.3seconds ,but after twelve weeks post TMT injection the 
escape latency improved to ~ 7.8 seconds (Fig 2).  
The total time that rats spent in goal quarter during probe trial on the fifth day of testing (the 
platform has been removed) was decreased significantly (p < 0.05) in TMT group after one weeks 
when compared with TMT group after twelve weeks. The mean quadrant time for non-lesion rats 
after training was ~32.9 seconds while for TMT lesioned group after four weeks was ~24.2 seconds, 
and, ~29.6 seconds after twelve weeks post TMT injection (Fig 2). To be certain that the TMT 
didn’t impairing the animals’ vision or changing the motivation to escape from water; in which 
affect the task results, the two groups were run on cued version of the task.  
MWM Test for CNTs/OBNSCs engrafted Group  
 The results of the test is not reliable because the significance improvement of learning ability and 
memory of rats due to endogenous neurogenesis pathway before engraftment of OBNSCs/CNTs 
(Supplementary Figure S1). So, we cannot prove that the improvement in memory and cognition 
from our engrafted OBNSCs/CNTs because there were two different variables, the endogenous and 
exogenous neurogenesis. Based on this observation, we restricted our assessment to test the ability 
of engrafted OBNSCs/CNTs to survive, proliferate, and differentiated into different types of 
neuronal, and glial elements using immunohistochemical protocol. In our opinion assessment of the 
survival, proliferation and differentiation potential of the engrafted GFP-OBNSCs/CNTs is the most 
important and decisive findings if we want to provide a conclusive evidence about the potential use 
of OBNSCs/CNTs for cell-based therapy. Here, we traced our engrafted OBNSCs/CNTs based on 
their positive reactivity to GFP, and we differentiated between neuronal and glial cells based on 
nuclear morphology which is one important criterial to differentiate between neuronal and glial 
cells at LM level.  
Immunohistochemical Assessment for the Engrafted GFP-OBNSCs/CNTs 
In the present study, we had genetically engineered the human OBNSCs to overexpress green 
fluorescent protein (GFP) to trace the engrafted OBNSC, and to differentiate between our engrafted 
(exogenous), and endogenous neuronal and glial elements. The performed immunocytochemical 
using anti-GFP antibodies confirmed the ability of engrafted cells to survive, proliferate, and 
differentiated into different types of neuronal and glial cells following engraftment of GFP-
OBNSCs/CNTs in the CA1 region of hippocampus. The GFP-OBNSCs/CNTs survived in the 
lesion environment for more than eight weeks after implantation, and no tumor formation was 
recorded during the lifetime window of the eight weeks.  
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Brain sections were processed for immunostaining to determine the grafted cells by using Anti-
GFP. Using enzymatic immunohistochemistry microscopy, GFP-expressing cells were found to 
migrate from injection site into the deeper layers of the tissue. One week post GFP-OBNSCs/CNTs 
engraftment, GFP-expressing cells were detected in various depths of hippocampus where they 
appeared as GFP-positive dark brown granules in their cytoplasm (Fig 3. A, B, C). After two weeks, 
GFP-positive cells with morphological criteria suggestive of mature neurons, astrocytes, and 
oligodendrocytes were identified. (Fig. 3 D). The number of these cells increased by 4 weeks, and 
by six weeks, GFP neuronal and glial cells (astrocytes, and oligodendrocytes) were identified within 
different hippocampal fields indicating their migration (Fig. 3 E, F). By eight weeks post the 
engraftment, GFP-positive cells with morphological criteria suggestive of mature neurons were 
recognized (Fig. 3 G), and (Figs. 4 A, B, C, D, E, F, G, H, I). During the eight weeks’ time 
window of the present study, 60, 17, and 23% of the engrafted cells were differentiated into 
neurons, oligodendrocytes, and astrocytes (supplementary Figure 2). 
Histological assessment following engraftment of GFP-OBNSCs/CNTs revealed gradual restoration 
of  pyramidal neuron within CA1 normal with very little necrotic neurons with mild improvement 
in pyramidal layer thickness. By eight weeks restoration of normal architecture and pyramidal cell 
layer were observed (Fig. 5 A, B, C, D, E, F). The granular layer of DG restored its normal 
architecture and cellular content and thickness (Fig. 5 G, H, I). 
Four weeks post the Engraftment of GFP-OBNSCs/CNTs, the CA3 neurons and oligodendrocyte  
increase its number with remnant of necrotic cells (Fig. 6 A). By eight weeks  restoration normal 
structure were seen (Fig. 6 B). By Eight weeks, restoration of pyramidal cell layer thickness 
(increase in thickness) to normal and restore cellular architecture with blue stain cytoplasm due to 
Nissl granules (Fig. 6 C, E, F, G, H, I, J, K, L) 
Discussion 
Here, we developed an animal model of Alzheimer's disease (AD) using TMT to elucidate the 
potential utility of human olfactory bulb NSCs carried on carbon nanotubes as scaffolds for cellular-
based therapy of neurodegenerative changes, and their ability to increase the survival of grafted 
NSCs. 
 
The OBNSCs were infected with lentivirus transducing GFP gene, according to protocol set up by 
(29). Martinez-Serrano and Bjorklund (31) and Brustle et al. (32) demonstrated that NSC have the 
capacity to grow indefinitely and are able to differentiate into three major cell types of CNS, 
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neurons, astrocytes and oligodendrocytes. In human, existence of NSCs with multipotent 
differentiation capability has also been reported in embryonic and adult human brain (33, 34).  
 
In many of the previous studies, the beneficial effects of NSCs transplantation had never reached 
the full histological and functional recovery. Several factors such as insufficient number, inability 
of the engrafted NSC to reach the intend site of injury, and inappropriate niche or 
microenvironment at the site of lesion might contribute to this limitations. This had prompted us to 
combine several technology with the aim to enhance the regenerative capacity of NSCs. Toward 
this objective, previous studies had infected NSCs with human nerve growth factor (hNGF) which 
were reported to enhance the proliferation capability of NSCs. Administration of nerve growth 
factor (NGF) in the CNS tissue is a potential treatment for preventing degeneration of basal 
forebrain cholinergic neurons in AD (35).  
 
To tackle the problem of in ability of NSCs to reach the intended pathological site, we co-engrafted 
our cells with CNTs which would provide a scaffolds to carry the NSCs to the site of injury 
providing a mechanical support and help the adhesion and differentiation of cells. It could also 
allow the transitions of electrical impulses and connectivity between cells. Finally, we have also 
infected our OBNSCs with GFP as a tracer marker to follow up the proliferation, and differentiation 
ability of engrafted OBNSCs. 
 
To test the efficacy of OBNSCs/CNTs to restore neurodegenerative changes, we developed a TMT-
neurodegeneration model by intraperitoneal administration of TMT in our rat model (26). After two 
weeks of TMT administration, the neurodegenerative changes were associated with a pronounced 
inflammatory response, neuronal death, loss of Nissl granules, gliosis, and congestion of blood 
capillary. Extensive cellular necrosis of pyramidal neuron of CA1 and granular layer of DG and 
neuron of CA3 were also revealed. The mechanism by which TMT  induce neuronal necrosis is still 
under dispute. TMT might induce its neurotoxic effects through glutamate excitotoxicity, 
intracellular calcium overload and impairment of neurotransmission (36, 37),  along with oxidative 
stress and HPSP activation (38-41). 
 
In the present study, The TMT-lesioned rats have shown a profound Morris water maze deficit after 
4 weeks post TMT injection. TMT administration was associated with impairment of spatial 
memory and cognitive functions creating cytotoxic neurodegeneration model ready to be used for  
assessment  the therapeutic potential of OBNSC/CNTs-based therapy, and their ability to restore 
cognitive and memory deficit induced by TMT administration.  
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To avoid any problems with the niche or microenvironment of the NSCs we start the engraftment of  
OBNSCs/CNTs after subsidence of the inflammatory phase post TMT injection to avoid the 
inflammatory mediators and any substances or the remnants of the neurotoxicant that may affect the 
implanted cells. The present study revealed that following engraftment, the OBNSCs/CNTS 
survived in the lesion environment for more than eight weeks. Moreover, no tumor formation was 
recorded during the lifetime window of the current study.  
 
Next, we performed histological and immunohistochemical assessment to evaluate the way by 
which engrafted GFP-OBNSCs/CNTs were able to restore the hippocampal histo-architecture. The 
transplanted OBNSCs/CNTs were assessed 1, 2, 4, 6 and 8 weeks following implementation into 
hippocampal formation. Sections from the two hippocampi were processed for double 
immunostaining to trace the fate of the engrafted GFP-OBNSCs by using Anti-GFP and cell type-
specific markers.  Using enzymatic immunohistochemistry, GFP-expressing cells were localized 
initially near the site of injection then migrate from injection site into the deeper layers with time.  
 
Two weeks later, GFP-positive cells with morphological criteria suggestive of mature neurons, 
astrocytes, and oligodendrocytes were identified within the stratum pyramidale of the hippocampus, 
beside normal endogenous non GFP-positive neuronal and glial cells. Six week after 
transplantation, positive GFP neuronal and glial cells (astrocytes, and oligodendrocytes) within 
different hippocampal fields were identified indicating their migration away from the primary site 
for engraftment. 
 
The mechanism by which the transplanted GFP-OBNSCs/CNTs have exerted a positive influence 
both at cognitive and histo-architecture level are still not fully understood.  In the present study, the 
modified GFP-OBNSCs survived and differentiated into different types of neuronal and glial 
elements including neurons, astrocytes, and oligodendrocytes.  The transplanted cells migrate 
within damaged areas and promote repair or neuroprotection via cell replacement, integration 
and/or neuroprotection. Also the endogenous pathway of neurogenesis reported to improve memory 
and cellular architecture following TMT injection (42).  
 
The role of hNGF in enhancement the regenerative capacity of NSC has been described before. 
Engraftment of fibroblasts encoding NGF gene in the primate brain had rescued the degenerating 
basal forebrain cholinergic neurons. So, genetic engineering of different cell sources to over-express 
the hNGF genes seems to be a promising strategy for direct intraventricular delivery of hNGF into 
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the brain tissue (43). In our previous study, human olfactory bulb neural stem cells (OBNSC) with 
transgenic expression of human nerve growth factor (hNGF) were demonstrated to restore cognitive  
deficit and neuronal losses associated with ibeitonic acid (IBO) AD rat model. The OBNSCs were 
stably transduced with hNGF and enhanced green fluorescent protein (eGFP) genes (GFP-
OBNSCs) by using a recombination lentiviral expression vectors (8).  
 
Here, the combined use of OBNSCs with CNTs seems to enhance the proliferation and 
differentiation potential of OBNSCs as revealed by their ability to restore cognitive and 
neurodegenerative changes associated with ATM administration. Previous studies demonstrated that 
the physical and mechanical support provided by CNTs help the seeded NSCs to adhere and 
differentiate at the site of lesion (21). The CNTs allowed for a favorable substrate for the neural 
stem cells for adherence so, keeping them in the local environment that they could be stimulated to 
differentiate into neurons by the conductive carbon nanotubes (44). These findings were in harmony 
with those reported in the present study where we found that most of the engrafted cells were 
differentiated into neuron. CNTs are not biodegradable so it could be used as an implant where 
long-term molecular cues for neurite outgrowth are necessary, such as in regeneration after spinal 
cord or brain injury. Moreover that, their chemical prosperities are not interfering the cellular 
proliferation and differentiation (45). The use of multiwalled CNTs  reduced glial cells (gliosis) 
specially to astrocytes which is the major component of glial scar and this lead to overcome the 
major obstacle in tissue repair and regeneration after injury in CNS (45). This could explained the 
marked tendency of our engrafted GFP-OBNSCs to differentiate into neurons rather than astrocytes. 
The use of CNTs coated with neurotropic factor like NGF would help in neurite outgrowth of 
neuron (46). Finally the unique electrical prosperities of CNTs might help interaction and allow 
electrical impulses to pass through tissue engineered scaffold, and thus help to restore function (47). 
Taken together, the present study revealed that human OBNSCs expressing NGF carried on CNTs 
scaffolds are promising candidates for the cell-based gene therapy for neurodegenerative diseases.  
 
To underlie the effects of nanotube alone or cells alone, we compared the outcome of the 
additive/synergistic effects of the two modalities with our previous findings (8, 9) regarding the use 
of human OBNSCs alone  without CNTs scaffolds. The enhanced neuronal differentiation potential 
observed here might confirm our findings regarding the role of CNTs scaffolds in enhancing the 
tendency of engrafted GFP-OBNSCs to differentiate into neurons rather than astrocytes. 
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Conclusion 
Using a combined treatment of human olfactory bulb neural stem cells (OBNSCS), and CNTs, the 
present study demonstrated the marked potential of OBNSCs/CNTs for cell-based therapy of TMT 
neurodegenerative rat model. The engrafted OBNSCS/CNTs were traced using GFP, and their 
differentiation into different neuronal and glial cells were assessed based on their nuclear 
morphology. Such protocol proved its reliability and provided a strong morphological and 
immunohistochemical evidence for successful integration of engrafted OBNSCs/CNTs with 
existing neuronal circuitry. Using CNTs as scaffold was very helpful for support and promote NSCs 
implantation and promote its differentiation and functions. OBNSCS impregnated in CNT increased 
the differentiation of NSCs to neurons and decreased astrocytes formation, a finding that indicate 
the marked ability to restore TMT-neurodegenerative lesion, and qualify them as promising 
candidates for the cell-based for different neurodegenerative diseases. 
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Legends of Figures 
Figure 1: Photomicrograph of a section of rat's hippocampus two weeks post TMT-administration 
showing congestion of blood capillary, edema with degenerative changes in CA1 pyramidal 
neurons (A), neuronal necrosis (B, C), proliferation of glial cells (D, E), neuronal death in granular 
layer of DG and CA3 (F, G, H, I). H&E and cresyl violet. 
Figure 2: Chart for escape latency and quadrant time before TMT, after one week and after 12 
weeks post TMT administration to evaluate the impairment of memory. Note impairment of 
memory after four weeks followed by improvement of memory after 8 weeks. The chart indicates 
active auto-neurogenesis which made assessment of improvement due to engrafted OBNSC 
unreliable.  
Figure 3: Photomicrograph of a section from rat's hippocampus (one week post OBNSC/CNTs 
engraftment) stained for GFP through indirect detection using  Biotin-Conjugated Goat Anti Rabbit 
Secondary Antibody, Poly-Horseradish peroxidase (HRP) conjugate and Metal Enhanced DAB to develop 
the signal (brown color) (arrows). Note, the GFP-positive neurons within the stratum pyramidale indicating 
the survival of OBNSC (A, B, C), and their differentiation into neurons, oligodendrocyte and astrocyte 
like GFP- positive cells (arrows) (D). By six week, GFP neuronal and glial cells (astrocytes, and 
oligodendrocytes) were identified within different hippocampal fields indicating their migration 
(Fig. 3 E, F). By eight weeks post the engraftment, GFP-positive cells with morphological criteria 
suggestive of mature neurons were recognized (Fig. 3 G), and Figure 4 A, B, C, D, E, F, G, H, I). 
HRP-enzyme IHC. 
Figure 4: Photomicrograph of a section from rat's hippocampus (eight-week post GFP-
OBNSC/CNTs engraftment) showing GFP- positive cells (arrow) (A), GFP- positive cells (arrow) 
astrocyte like cells (B), GFP- positive cells (arrows)  oligodendrocyte like cell (C, D, E), GFP- 
positive cells (arrow) neuron (N), oligodendrocyte (O) like cells (F), GFP- positive cells (arrow) (G, 
H), GFP- positive cells "neuron" (arrow) (I).   
Figure 5: Photomicrograph of a section of rat's hippocampus eight weeks post (OBNSC/CNTs 
engraftment) showing normal pyramidal neurons of CA1 (A, B, C, D, E, F). The granular layer of 
DG restored its normal architecture and cellular content and thickness (Fig. 5 G, H, I). H&E. 
Figure 6: Photomicrograph of a section of rat's hippocampus four weeks post (OBNSC/CNTs 
engraftment) showing pyramidal normal neurons of CA1 with clear Nissl granules (A), reduction of 
necrotic cells (B). By Eight weeks, restoration of pyramidal cell layer thickness (increase in 
20  This article is protected by copyright. All rights reserved 
thickness) to normal and restore cellular architecture with blue stain cytoplasm due to Nissl 
granules (Fig. 6 C, E, F, G, H, I, J, K, L). cresyl violet stain. 
 
 
  
21  This article is protected by copyright. All rights reserved 
 
Figure 1 
 
  
22  This article is protected by copyright. All rights reserved 
 
Figure 2 
 
  
23  This article is protected by copyright. All rights reserved 
 
Figure 3 
 
24  This article is protected by copyright. All rights reserved 
 
 4erugiF  
25  This article is protected by copyright. All rights reserved 
 
 5erugiF  
26  This article is protected by copyright. All rights reserved 
 
 6erugiF  
 
 
 
